Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 88.59B | 87.93B | 87.69B | 90.16B | 93.51B | 83.79B |
Gross Profit | 20.41B | 19.00B | 18.95B | 19.17B | 20.17B | 17.79B |
EBITDA | 10.14B | 10.49B | 10.87B | 10.23B | 9.55B | 11.26B |
Net Income | 4.12B | 4.09B | 4.33B | 3.97B | 3.83B | 5.23B |
Balance Sheet | ||||||
Total Assets | 88.42B | 87.63B | 87.01B | 87.11B | 85.99B | 82.78B |
Cash, Cash Equivalents and Short-Term Investments | 6.17B | 5.57B | 6.50B | 6.86B | 6.90B | 7.09B |
Total Debt | 37.91B | 37.42B | 37.72B | 38.33B | 37.19B | 36.46B |
Total Liabilities | 60.65B | 59.55B | 59.42B | 61.05B | 61.05B | 58.61B |
Stockholders Equity | 27.77B | 28.07B | 27.58B | 26.09B | 24.94B | 24.17B |
Cash Flow | ||||||
Free Cash Flow | 3.65B | 2.98B | 3.14B | 2.64B | 3.07B | 4.25B |
Operating Cash Flow | 7.57B | 7.04B | 8.31B | 8.81B | 9.83B | 10.13B |
Investing Cash Flow | -3.91B | -4.09B | -5.20B | -6.17B | -6.82B | -6.01B |
Financing Cash Flow | -3.51B | -4.02B | -3.43B | -2.60B | -3.02B | -2.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $56.11B | 13.90 | 14.98% | 2.38% | 1.14% | 4.99% | |
72 Outperform | $16.54B | 19.88 | 38.85% | 1.23% | 23.70% | 31.33% | |
72 Outperform | $15.02B | 13.21 | 14.21% | 3.63% | 14.40% | 2.41% | |
69 Neutral | $70.96B | 12.45 | 34.59% | 7.82% | 0.94% | 9.62% | |
69 Neutral | $15.57B | 30.01 | 29.94% | 1.88% | -2.55% | 59.07% | |
67 Neutral | $14.84B | 43.60 | 19.37% | ― | -0.11% | -4.28% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |